Efficacy of Weekly Split Versus Single Doses of Ergocalciferol on Serum 25-Hydroxyvitamin D Among Patients on Continuous Ambulatory Peritoneal Dialysis: A Randomized Controlled Trial

Overview

Journal Int J Nephrol

Publisher Wiley

Specialty Nephrology

Date 2021 Apr 1

PMID 33791128

Authors

Naowanit Nata

Jessada Kanchanasinitth

Pamila Tasanavipas

Ouppatham Supasyndh

Bancha Satirapoj

Affiliations

Soon will be listed here.

Abstract

Background: Vitamin D deficiency is a common problem among patients on continuous ambulatory peritoneal dialysis (CAPD). Vitamin D supplementation leads to reduced serum parathyroid hormone levels and improved cardiovascular markers. Different doses and time intervals of oral vitamin D supplementation may differ in each patient on dialysis. The study aimed to evaluate the efficacy of weekly split and single dose of ergocalciferol at 60,000 IU on serum 25-hydroxyvitamin D (25(OH)D) among patients on CAPD.

Methods: A randomized study was conducted among patients on CAPD with vitamin D deficiency or insufficiency (25(OH)D < 30 ng/mL). Patients were randomly assigned to two groups: the split dose group was given ergocalciferol 20,000 IU three times weekly and the single dose group was given ergocalciferol 60,000 IU once weekly for 8 weeks. Main outcomes measured serum 25(OH)D concentrations, serum calcium, serum phosphate, and intact parathyroid levels at 8 weeks after being enrolled.

Results: Of 128 screened patients, 50 met the criteria for eligibility and were randomized. At 8 weeks after treatment, mean serum 25(OH)D concentrations significantly increased from baseline 22.7 ± 5.9 to 29.5 ± 9.5 ng/mL (=0.004) in the split dose group and 22.9 ± 5.3 to 31.2 ± 12.3 ng/mL (=0.003) in the single dose group. No significant change was found in increase of serum 25(OH)D between the two groups (=0.561). At the end of study, a similar proportion of patients in both groups reached the desirable serum concentration of 25(OH)D ≥ 30 ng/mL (60% in the single group vs. 40% in the split group, =0.258). No significant cases of hypercalcemia, hyperphosphatemia, or serious adverse events occurred during the study.

Conclusion: Weekly single and split doses of ergocalciferol 60,000 IU achieved similar effects on serum 25(OH)D levels among patients on CAPD with vitamin D insufficiency or deficiency, suggesting that weekly single dose would be prescribed for adequate vitamin D repletion. This trial is registered with TCTR20200821005.

References

Mieczkowski M, Zebrowski P, Wojtaszek E, Stompor T, Przedlacki J, Bartoszewicz Z . Long-term cholecalciferol administration in hemodialysis patients: a single-center randomized pilot study. Med Sci Monit. 2014; 20:2228-34. PMC: 4238795. DOI: 10.12659/MSM.892315. View

Satirapoj B, Limwannata P, Chaiprasert A, Supasyndh O, Choovichian P . Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population. BMC Nephrol. 2013; 14:206. PMC: 3850679. DOI: 10.1186/1471-2369-14-206. View

Deluca H . Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004; 80(6 Suppl):1689S-96S. DOI: 10.1093/ajcn/80.6.1689S. View

. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42(4 Suppl 3):S1-201. View

Kandula P, Dobre M, Schold J, Schreiber Jr M, Mehrotra R, Navaneethan S . Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol. 2010; 6(1):50-62. PMC: 3022248. DOI: 10.2215/CJN.03940510. View

Kearns M, Alvarez J, Tangpricha V . Large, single-dose, oral vitamin D supplementation in adult populations: a systematic review. Endocr Pract. 2013; 20(4):341-51. PMC: 4128480. DOI: 10.4158/EP13265.RA. View

London G, Guerin A, Verbeke F, Pannier B, Boutouyrie P, Marchais S . Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007; 18(2):613-20. DOI: 10.1681/ASN.2006060573. View

Matias P, Jorge C, Ferreira C, Borges M, Aires I, Amaral T . Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol. 2010; 5(5):905-11. PMC: 2863968. DOI: 10.2215/CJN.06510909. View

Massart A, Debelle F, Racape J, Gervy C, Husson C, Dhaene M . Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial. Am J Kidney Dis. 2014; 64(5):696-705. DOI: 10.1053/j.ajkd.2014.04.020. View

10.

Chel V, Wijnhoven H, Smit J, Ooms M, Lips P . Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int. 2007; 19(5):663-71. PMC: 2277446. DOI: 10.1007/s00198-007-0465-2. View

11.

Wetmore J, Kimber C, Mahnken J, Stubbs J . Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial. Br J Nutr. 2017; 116(12):2074-2081. PMC: 6036626. DOI: 10.1017/S000711451600427X. View

12.

Giusti A, Barone A, Pioli G, Girasole G, Razzano M, Pizzonia M . Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency. J Am Geriatr Soc. 2010; 58(8):1489-95. DOI: 10.1111/j.1532-5415.2010.02970.x. View

13.

Bhan I, Dobens D, Tamez H, Deferio J, Li Y, Warren H . Nutritional vitamin D supplementation in dialysis: a randomized trial. Clin J Am Soc Nephrol. 2015; 10(4):611-9. PMC: 4386253. DOI: 10.2215/CJN.06910714. View

14.

Bunyaratavej N . Study of the Safe Dosage of Ergocalciferol. J Med Assoc Thai. 2015; 98 Suppl 8:S13-5. View

15.

Mager D, Jackson S, Hoffmann M, Jindal K, Senior P . Vitamin D supplementation, bone health and quality of life in adults with diabetes and chronic kidney disease: Results of an open label randomized clinical trial. Clin Nutr. 2016; 36(3):686-696. DOI: 10.1016/j.clnu.2016.05.012. View

16.

Malabanan A, Veronikis I, Holick M . Redefining vitamin D insufficiency. Lancet. 1998; 351(9105):805-6. DOI: 10.1016/s0140-6736(05)78933-9. View

17.

Barros X, Rodriguez N, Fuster D, Rodas L, Esforzado N, Mazza A . Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients. J Nephrol. 2015; 29(5):703-9. DOI: 10.1007/s40620-015-0237-6. View

18.

Premaor M, Scalco R, da Silva M, Froehlich P, Furlanetto T . The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit. J Bone Miner Metab. 2008; 26(6):603-8. DOI: 10.1007/s00774-008-0858-0. View

19.

Ish-Shalom S, Segal E, Salganik T, Raz B, Bromberg I, Vieth R . Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab. 2008; 93(9):3430-5. DOI: 10.1210/jc.2008-0241. View

20.

Zhang Q, Zhang M, Wang H, Sun C, Feng Y, Zhu W . Vitamin D supplementation improves endothelial dysfunction in patients with non-dialysis chronic kidney disease. Int Urol Nephrol. 2018; 50(5):923-927. DOI: 10.1007/s11255-018-1829-6. View